跳至主要内容
临床试验/RBR-5fwhf7
RBR-5fwhf7招募中1 期

Canabidiol in treatment of REM behavior sleep disorder associated with Parkinson's disease- a double-blind placebo controlled clinical trial - CBD-RBD study: CannaBiDiol-Rem Behavior Disorder estudo

niversidade de Sao Paulo0 个研究点开始时间: 2017年11月22日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

入选标准

  • Diagnosis of PD according to criteria of the London Brain Bank in stage 1-3 of the Hoehn and Yahr scale;Over 18 years of age;Diagnosis of RBD according to the criteria of the 3rd edition of the International Classification of Sleep Disorders (CIDS-3);With sufficient severity and frequency to indicate a symptomatic treatment, ie with a frequency of 2 or more episodes per week;That they agree to participate in the study.

排除标准

  • In adjustment of antiparkinsonian medications; With diagnosis of dementia; Presenting significant hallucinations (score> 2 in the MDS-UPDRS psychosis item); Introducing delusions; With depression; Without a partner with whom you share your bedroom;With severe or decompensated systemic diseases;With probable mild TCSREM, with sporadic episodes and not clinically significant;Alcoholism or use of illicit drugs;Patients in stage 4-5 of the Hoehn and Yahr scale.

研究者

发起方
niversidade de Sao Paulo

相似试验